Search Results - "Rodriguez‐Lescure, Alvaro"

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study by Martín, Miguel, Ruiz Simón, Amparo, Ruiz Borrego, Manuel, Ribelles, Nuria, Rodríguez-Lescure, Álvaro, Muñoz-Mateu, Montserrat, González, Sonia, Margelí Vila, Mireia, Barnadas, Agustí, Ramos, Manuel, Del Barco Berron, Sonia, Jara, Carlos, Calvo, Lourdes, Martínez-Jáñez, Noelia, Mendiola Fernández, César, Rodríguez, César A, Martínez de Dueñas, Eduardo, Andrés, Raquel, Plazaola, Arrate, de la Haba-Rodríguez, Juan, López-Vega, Jose Manuel, Adrover, Encarna, Ballesteros, Ana Isabel, Santaballa, Ana, Sánchez-Rovira, Pedro, Baena-Cañada, José M, Casas, Maribel, del Carmen Cámara, María, Carrasco, Eva Maria, Lluch, Ana

“…Capecitabine is an active drug in metastatic breast cancer (BC). GEICAM/2003-10 is an adjuvant trial to investigate the integration of capecitabine into a…”
Get full text

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer by Martín, Miguel, Prat, Aleix, Rodríguez-Lescure, Álvaro, Caballero, Rosalía, Ebbert, Mark T. W., Munárriz, Blanca, Ruiz-Borrego, Manuel, Bastien, Roy R. L., Crespo, Carmen, Davis, Carole, Rodríguez, César A., López-Vega, José M., Furió, Vicente, García, Ana M., Casas, Maribel, Ellis, Matthew J., Berry, Donald A., Pitcher, Brandelyn N., Harris, Lyndsay, Ruiz, Amparo, Winer, Eric, Hudis, Clifford, Stijleman, Inge J., Tuck, David P., Carrasco, Eva, Perou, Charles M., Bernard, Philip S.

“…To identify a group of patients who might benefit from the addition of weekly paclitaxel to conventional anthracycline-containing chemotherapy as adjuvant…”
Get full text

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study by MARTIN, Miguel, RUIZ, Amparo, MUNOZ-MATEU, Montserrat, DORCA RIBUGENT, Joan, LOPEZ-VEGA, José Manuel, JARA, Carlos, ESPINOSA, Enrique, MENDIOLA FERNANDEZ, César, ANDRES, Raquel, RIBELLES, Nuria, PLAZAOLA, Arrate, SANCHEZ-ROVIRA, Pedro, RUIZ BORREGO, Manuel, SALVADOR BOFILL, Javier, CRESPO, Carmen, CARABANTES, Francisco J, SERVITJA, Sonia, IGNACIO CHACON, José, RODRIGUEZ, César A, HERNANDO, Blanca, ALVAREZ, Isabel, CARRASCO, Eva, LLUCH, Ana, BARNADAS, Agustí, GONZALEZ, Sonia, CALVO, Lourdes, MARGELI VILA, Mireia, ANTON, Antonio, RODRIGUEZ-LESCURE, Alvaro, SEGUI-PALMER, Miguel Angel

“…Adding taxanes to anthracycline-based adjuvant therapy improves survival outcomes of patients with node-positive breast cancer (BC). Currently, however, most…”
Get full text

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer by Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix

“…In hormone receptor-positive (HR+)/HER2-negative breast cancer, the HER2-enriched and Basal-like intrinsic subtypes are associated with poor outcome, low…”
Get full text

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile by González-Martín, Antonio, Alba, Emilio, Ciruelos, Eva, Cortés, Javier, Llombart, Antonio, Lluch, Ana, Andrés, Raquel, Álvarez, Isabel, Aramendía, José Manuel, de la Peña, Francisco Ayala, Barnadas, Agustí, Batista, Norberto, Calvo, Lourdes, Galve, Elena, García-Palomo, Andrés, García-Sáenz, José Ángel, de la Haba, Juan, López, Rafael, López-Vivanco, Guillermo, Martínez-Jáñez, Noelia, de Dueñas, Eduardo Martínez, Plazaola, Arrate, Rodríguez-Lescure, Álvaro, Ruiz, Manuel, Sánchez-Rovira, Pedro, Santaballa, Ana, Seguí, Miguel Ángel, Tusquets, Ignasi, Zamora, Pilar, Martín, Miguel

“…Around 40% of patients with breast cancer will present with a recurrence of the disease. Chemotherapy is recommended for patients with recurrent…”
Get more information

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression by Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez‐Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz‐Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.

“…Purpose. To determine intrinsic breast cancer subtypes represented within categories defined by quantitative hormone receptor (HR) and HER2 expression…”
Get full text

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial by Mackey, John R, Prof, Martin, Miguel, Prof, Pienkowski, Tadeusz, Prof, Rolski, Janusz, MD, Guastalla, Jean-Paul, MD, Sami, Amer, MD, Glaspy, John, MD, Juhos, Eva, MD, Wardley, Andrew, MD, Fornander, Tommy, MD, Hainsworth, John, MD, Coleman, Robert, MD, Modiano, Manuel R, MD, Vinholes, Jeferson, MD, Pinter, Tamas, MD, Rodríguez-Lescure, Álvaro, MD, Colwell, Bruce, MD, Whitlock, Pierre, MD, Provencher, Louise, MD, Laing, Kara, MD, Walde, David, MD, Price, Chris, MD, Hugh, Judith C, MD, Childs, Barrett H, MD, Bassi, Kimberly, BS, Lindsay, Mary-Ann, PharmD, Wilson, Véronique, MSc, Rupin, Matthieu, MSc, Houé, Vincent, MSc, Vogel, Charles, MD

“…Summary Background We compared standard adjuvant anthracycline chemotherapy with anthracycline–taxane combination chemotherapy in women with operable…”
Get full text

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers by Bastien, Roy R L, Rodríguez-Lescure, Álvaro, Ebbert, Mark T W, Prat, Aleix, Munárriz, Blanca, Rowe, Leslie, Miller, Patricia, Ruiz-Borrego, Manuel, Anderson, Daniel, Lyons, Bradley, Álvarez, Isabel, Dowell, Tracy, Wall, David, Seguí, Miguel Ángel, Barley, Lee, Boucher, Kenneth M, Alba, Emilio, Pappas, Lisa, Davis, Carole A, Aranda, Ignacio, Fauron, Christiane, Stijleman, Inge J, Palacios, José, Antón, Antonio, Carrasco, Eva, Caballero, Rosalía, Ellis, Matthew J, Nielsen, Torsten O, Perou, Charles M, Astill, Mark, Bernard, Philip S, Martín, Miguel

“…Many methodologies have been used in research to identify the "intrinsic" subtypes of breast cancer commonly known as Luminal A, Luminal B, HER2-Enriched…”
Get full text

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer by Martín, Miguel, Seguí, Miguel A, Antón, Antonio, Ruiz, Amparo, Ramos, Manuel, Adrover, Encarna, Aranda, Ignacio, Rodríguez-Lescure, Alvaro, Große, Regina, Calvo, Lourdes, Barnadas, Agustí, Isla, Dolores, Martinez del Prado, Purificación, Ruiz Borrego, Manuel, Zaluski, Jerzy, Arcusa, Angels, Muñoz, Montserrat, López Vega, José M, Mel, José R, Munarriz, Blanca, Llorca, Cristina, Jara, Carlos, Alba, Emilio, Florián, Jesús, Li, Junfang, López García-Asenjo, José A, Sáez, Amparo, Rios, María José, Almenar, Sergio, Peiró, Gloria, Lluch, Ana

“…As compared with the standard regimen, the combination of docetaxel, doxorubicin, and cyclophosphamide reduced the risk of recurrence of node-negative…”
Get full text

Lack of cytomegalovirus detection in human glioma by Garcia-Martinez, Araceli, Alenda, Cristina, Irles, Esperanza, Ochoa, Enrique, Quintanar, Teresa, Rodriguez-Lescure, Alvaro, Soto, Jose L, Barbera, Victor M

“…Gliomas are the most common brain tumors and include a variety of histologic types and grades of malignancy. They arise from glial cells and represent…”
Get full text

Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab by Bueno-Muiño, Coralia, Echavarría, Isabel, López-Tarruella, Sara, Roche-Molina, Marta, Del Monte-Millán, María, Massarrah, Tatiana, Jerez, Yolanda, Ayala de la Peña, Francisco, García-Sáenz, José Ángel, Moreno, Fernando, Rodríguez-Lescure, Álvaro, Malón-Giménez, Diego, Ballesteros García, Ana Isabel, Marín-Aguilera, Mercedes, Galván, Patricia, Brasó-Maristany, Fara, Waks, Adrienne G, Tolaney, Sara M, Mittendorf, Elizabeth A, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S, Perou, Charles M, Paré, Laia, Villacampa, Guillermo, Prat, Aleix, Martín, Miguel

“…Biomarkers to guide the use of pertuzumab in the treatment of early-stage ERBB2 (formerly HER2)-positive breast cancer beyond simple ERBB2 status are needed…”
Get more information

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper by Bouza, E, Martin, M, Alés, J E, Aragonés, N, Barragán, B, de la Cámara, R, Del Pozo, J L, García-Gutiérrez, V, García-Sanz, R, Gracia, D, Guillem, V, Jiménez-Yuste, V, Martin-Delgado, M C, Martínez, J, López, R, Rodríguez-Lescure, A, Ruiz Galiana, J, Sureda, A M, Tejerina-Picado, F, Trilla, A, Zapatero, A, Palomo, E, San-Miguel, J

“…We do not know the precise figure for solid organ tumors diagnosed each year in Spain and it is therefore difficult to calculate whether there has been a…”
Get full text

Adjuvant chemotherapy in young women with breast cancer by Rodríguez-Lescure, Álvaro

“…The issue of whether young women with breast cancer should be treated differently from older women is a matter of debate, partly because of the lack of…”
Get full text

PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines by Carrasco-Garcia, Estefania, Martinez-Lacaci, Isabel, Mayor-López, Leticia, Tristante, Elena, Carballo-Santana, Mar, García-Morales, Pilar, Ventero Martin, Maria Paz, Fuentes-Baile, Maria, Rodriguez-Lescure, Álvaro, Saceda, Miguel

“…Glioblastomas are highly resistant to radiation and chemotherapy. Currently, there are no effective therapies for this type of tumor. Signaling mechanisms…”
Get full text

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone by Sestak, Ivana, Martín, Miguel, Dubsky, Peter, Kronenwett, Ralf, Rojo, Federico, Cuzick, Jack, Filipits, Martin, Ruiz, Amparo, Gradishar, William, Soliman, Hatem, Schwartzberg, Lee, Buus, Richard, Hlauschek, Dominik, Rodríguez-Lescure, Alvaro, Gnant, Michael

“…Purpose EndoPredict (EPclin) is a prognostic test validated to inform decisions on adjuvant chemotherapy to endocrine therapy alone for patients with oestrogen…”
Get full text

SEOM clinical guidelines for the treatment of early breast cancer by del Barco Berrón, Sonia, Ciruelos Gil, Eva, Tusquets Trías de Bes, Ignacio, Muñoz Mateu, Montserrat, Sánchez Rovira, Pedro, Rodríguez Lescure, Álvaro, Isla Casado, Dolores

“…The incidence is increasing due to mammographic screening and an ageing population. In some countries the mortality rate has decreased especially in middleaged…”
Get full text

SEOM clinical guidelines for the treatment of metastatic breast cancer by Álvarez López, Isabel, de la Haba Rodríguez, Juan, Ruiz Simón, Amparo, Bellet Ezquerra, Meritxell, Calvo Martínez, Lourdes, García Estévez, Laura, Rodríguez Lescure, Álvaro, Isla Casado, Dolores

“…Patients with metastatic breast cancer have a wide number of treatment options, including medical, surgical, and supportive care measures. Treatment decisions…”
Get full text

CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients? by Fuentes-Baile, María, Pérez-Valenciano, Elizabeth, García-Morales, Pilar, de Juan Romero, Camino, Bello-Gil, Daniel, Barberá, Víctor M, Rodríguez-Lescure, Álvaro, Sanz, Jesús M, Alenda, Cristina, Saceda, Miguel

“…D-amino acid oxidase (DAAO) is an enzyme that catalyzes the oxidation of D-amino acids generating H O . The enzymatic chimera formed by DAAO bound to the…”
Get full text

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis by Pajares, Bella, Pollán, Marina, Martín, Miguel, Mackey, John R, Lluch, Ana, Gavila, Joaquín, Vogel, Charles, Ruiz-Borrego, Manuel, Calvo, Lourdes, Pienkowski, Tadeusz, Rodríguez-Lescure, Álvaro, Seguí, Miguel Angel, Tredan, Olivier, Antón, Antonio, Ramos, Manuel, Cámara, María del Carmen, Rodríguez-Martín, César, Carrasco, Eva, Alba, Emilio

“…Obesity is an unfavorable prognostic factor in breast cancer (BC) patients regardless of menopausal status and treatment received. However, the association…”
Get full text

Advanced breast cancer: chemotherapy phase III trials that change a standard by Estevez, Laura G, Tusquets, Ignasi, Muñoz, Montse, Adrover, Encarnación, Rovira, Pedro Sánchez, Seguí, Miguel Ángel, Rodríguez, César A, Lescure, Álvaro Rodríguez, Ruiz, Manuel, Álvarez, Isabel, Mata, Jesús García

“…At the present time, there is not a standard regimen in upfront metastatic setting for breast cancer. A wide variety of regimens which includes anthracyclines,…”
Get full text